Results 171 to 180 of about 572,501 (357)

A long noncoding RNA GTF2IRD2P1 suppresses cell proliferation in bladder cancer by inhibiting the Wnt/β‑catenin signaling pathway

, 2022
Zhuo Huang, Hongbin Gao, Liangliang Qing, Biao Wang, Chaoyong He, Ning Luo, Chuncheng Lu, Shipeng Fan, Peng Gu, Hui Zhao   +9 more
openalex   +1 more source

The role of neutrophil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer [PDF]

, 2020
Orsolya Mártha, Daniel Bălan, Daniel Porav-Hodade, Emőke Drágus, Mihai Dorin Vartolomei, Călin Chibelean, Angela Borda, Ákos Pytel, O. Vida   +8 more
openalex   +1 more source

Halorotetin B, A Novel Terpenoid Compound Derived from Marine Ascidian, Suppresses Tumor Growth by Targeting the Cell Cycle Regulator UBE2C

Advanced Science, EarlyView.
Halorotetin B, a novel small‐molecule terpenoid identified from an edible marine ascidian, exhibits strong anti‐tumor activity both in vitro and in vivo through direct targeting UBE2C to induce tumor cell cycle arrest and then lead tumor cell senescence. As a newly discovered UBE2C inhibitor, Halorotetin B can serve as a novel potential cell senescence
Shanhao Han, Jianhui Li, Yuting Zhu, Penghui Liu, Yaoyao Zheng, Muchun He, Bo Dong   +6 more
wiley   +1 more source

CLINICAL ANALYSIS OF THE BLADDER CANCER

, 2006
Masahito Honda, Mototaka Satoh, Keiji Hasebe, Yuichi Tujimoto, Tuyoshi Takada, Hideki Fujioka   +5 more
openalex   +2 more sources

Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics

Advanced Science, EarlyView.
The ultimate goal of cancer theranostics is to get imaging agents and therapeutic cargo to tumor sites when and where they are required. “Smart” systems should be developed. This review discusses the characteristics of physiological stimuli, types and action modes of external stimuli, construction approaches and working principles, as well as ...
Wenting Hu, Binglin Ye, Guocan Yu, Feihe Huang, Zhengwei Mao   +4 more
wiley   +1 more source

Prothymosin‐α enhances phosphatase and tensin homolog expression and binds with tripartite motif‐containing protein 21 to regulate Kelch‐like ECH‐associated protein 1/nuclear factor erythroid 2‐related factor 2 signaling in human bladder cancer [PDF]

, 2019
Yuh‐Shyan Tsai, Yeong‐Chin Jou, Hsin‐Tzu Tsai, Ai‐Li Shiau, Chao‐Liang Wu, Tzong‐Shin Tzai   +5 more
openalex   +1 more source

Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology

Advanced Science, EarlyView.
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang, Jiangang Xu, Xinyu Zhou, Lu Che, Minghan Qiu, Yang Liu, Ming Gao, Zhen Yang   +7 more
wiley   +1 more source

Long non‑coding RNA 00858 knockdown alleviates bladder cancer via regulation of the miR‑3064‑5p/CTGF axis

, 2021
Ji Huang, Qiuming He, Qi Wu, Weimin Zhou, Chao Hao, Gongxian Wang, Xinhua Tu   +6 more
openalex   +2 more sources

USP35 Acts as a Deubiquitinating Enzyme for ID3 to Promote Immune Escape in Colorectal Cancer

Advanced Science, EarlyView.
USP35 stabilizes ID3 expression by deubiquitinating the K2/K30 site, thereby upregulating PD‐L1 and promoting immune escape in colorectal cancer. IU1, an inhibitor of USP35 enzyme activity, has been shown to inhibit USP35, thereby accelerating ID3 degradation, enhancing CD8+ T cell killing, and reversing the immunosuppressive microenvironment ...
Wenxin Chen, Ling Wang, Hongmei Fan, Lisheng Li, Lingyu Zhang, Ruoxin Li, Fang Liu, Fuli Wen, Yunbin Ye, Chuanzhong Huang   +9 more
wiley   +1 more source

Exploring Pembrolizumab-Induced IM3OS in a Patient With Bladder Cancer. [PDF]

Pharmacol Res Perspect
Chan CC, Lee MJ, Su J, Su JJ.
europepmc   +1 more source